NECTAR LIFESCIENCES
|
The Current P/E Ratio of NECTAR LIFESCIENCES is -3.28.
Share Price | ₹16.6 | Jul 30,2025 |
Market Cap | ₹373.0 Cr | |
Earnings-TTM | ₹-113.7 Cr | TTM-Consolidated Results |
Price/Earnings | -3.28x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of NECTAR LIFESCIENCES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹373.0 Cr] as on Jul 30,2025
(/) Earnings [ ₹-113.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ -3.28x ]
Thus, for NECTAR LIFESCIENCES , the investors are currently willing to pay -3.28 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of NECTAR LIFESCIENCES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of NECTAR LIFESCIENCES over the last five years.
Historical PE (Price/Earnings) ratio chart of NECTAR LIFESCIENCES
PE Ratio Performance Analysis for NECTAR LIFESCIENCES
- NECTAR LIFESCIENCES 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 32.72x.
- NECTAR LIFESCIENCES 's operated at median p/e ratio of 6.86x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, NECTAR LIFESCIENCES 's p/e ratio peaked in Mar2024 at 135.2x.
- NECTAR LIFESCIENCES 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does NECTAR LIFESCIENCES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
NECTAR LIFESCIENCES | -113.68 | -3.28 | 373.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,980.10 | 37.91 | 416,273.0 |
DIVIS LABORATORIES LTD | 2,191.00 | 80.60 | 176,604.0 |
CIPLA LTD | 5,406.81 | 23.30 | 125,993.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 63.09 | 126,316.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 18.82 | 107,795.0 |
MANKIND PHARMA LTD | 2,003.22 | 53.05 | 106,278.0 |
ZYDUS LIFESCIENCES LTD | 4,614.80 | 21.70 | 100,125.0 |
LUPIN LTD | 3,306.26 | 27.41 | 90,623.2 |
AUROBINDO PHARMA LTD | 3,515.26 | 19.12 | 67,198.8 |
ABBOTT INDIA LTD | 1,414.44 | 52.86 | 74,773.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs NECTAR LIFESCIENCES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | -3.28x |
Max industry PE | 80.60x |
Median industry PE | 27.41x |
Average industry PE | 35.87x |
You may also like the below Video Courses